Clinical Drug Experience Knowledgebase

Anemia (Phase 3)

Atrophy (Phase 1)

beta-Thalassemia (Phase 3)

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Charcot-Marie-Tooth Disease (Phase 2)

Familial Primary Pulmonary Hypertension (Phase 3)

Hereditary Sensory and Motor Neuropathy (Phase 2)

Hypertension (Phase 3)

Kidney Diseases (Phase 2)

Kidney Failure, Chronic (Phase 2)

Multiple Myeloma (Phase 1)

Muscular Atrophy (Phase 1)

Muscular Dystrophies (Phase 2)

Muscular Dystrophy, Duchenne (Phase 2)

Muscular Dystrophy, Facioscapulohumeral (Phase 2)

Musculoskeletal Diseases (Phase 1)

Myelodysplastic Syndromes (Phase 3)

Neoplasms, Plasma Cell (Phase 1)

Nerve Compression Syndromes (Phase 2)

Osteoporosis (Phase 1)

Preleukemia (Phase 3)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Syndrome (Phase 3)

Thalassemia (Phase 3)

Tooth Diseases (Phase 2)